A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis

Etanercept, a TNF receptor 2-Fc fusion protein, is currently being used for the treatment of rheumatoid arthritis (RA). However, 25% to 38% of patients show no response which is suspected to be partially due to insufficient affinity of this protein to TNFalpha. By using computational protein design,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS computational biology 2010-02, Vol.6 (2), p.e1000669-e1000669
Hauptverfasser: Yang, Tong, Wang, Zheng, Wu, Fang, Tan, Jingwei, Shen, Yijun, Li, Erguang, Dai, Jingzhi, Shen, Ronghai, Li, Gang, Wu, Jinsong, Wang, Luochun, Wang, Haibo, Liu, Yanjun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!